CD8A and neoplasm: The study encompassed a broad spectrum of immune markers, including those for T cells, CD8+ T cells, B cells, monocytes, neutrophils, NK cells, tumor-associated macrophages (TAMs), M1/M2 macrophages, and dendritic cells.